Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Antibodies Market, By Drug Type (Monoclonal antibodies, Polyclonal antibodies, Antibody-drug complexes (ADCs), by Disease Indication (CNS Disorders, Cardiovascular, Cancer, Autoimmune Disorders, COVID-19, Others) By End User (Hospitals, Long-term Care Facilities, Research institutes), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Antibodies are used in therapeutic applications for the treatment of diseases such as cancer, autoimmune ... Read More
-
Autoimmune Disease Diagnostics Market Forecasts to 2028 – Global Analysis By Disease Type (Localized Autoimmune Disease, Systemic Autoimmune Disease), Test Type (C-reactive Protein (CRP) Test, Antinuclear Antibody Test, Complete Blood Count (CBC), Urinalysis, Erythrocyte Sedimentation Rate (ESR), Comprehensive Metabolic Panel, Biopsy) and Others
... Rate (ESR), Comprehensive Metabolic Panel, Biopsy) and Others According tStratistics MRC, the Global Autoimmune Disease Diagnostics Market is accounted for $1198.9 billion in 2022 and is expected treach $1966.8 billion by 2028 growing at a ... Read More
-
Immunoglobulins: Global Market Outlook
... report surveys the competitive landscape, market dynamics and current and developing technologies. The report also analyzes the impact of COVID-19 on the market. In terms of geographical regions, the report analyzes the market across North ... Read More
-
In-vitro Diagnostics Market - By Product (Reagents & Kits, Instruments), By Test (Clinical Chemistry, Immunoassay, Hematology, Urinalysis), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Pharmacogenomics), By End-user (Hospitals, Diagnostic Laboratories) & Forecast, 2023 - 2032
... 2023 - 2032 In-vitro Diagnostics Market is anticipated to grow significantly from 2023 to 2032, owing to the constant improvements in the healthcare infrastructure and the increasing number of government and privately owned pathology labs. ... Read More
-
Biopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
... Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others) The biopharmaceuticals market is expected to grow from US$ 3,29,966.22 ... Read More
-
Middle East & Africa Injection Pen Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)
... and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others) The Middle East & Africa injection pen market is expected to grow from US$ 2,016.10 million in 2022 to US$ 2,872.94 million ... Read More
-
South America Injection Pen Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)
... Therapy), and End User (Hospitals and Clinics, Home Care, and Others) The South America injection pen market is expected to grow from US$ 2,389.84 million in 2022 to US$ 3,467.89 million by 2028. It is ... Read More
-
Europe Injection Pen Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)
... and End User (Hospitals and Clinics, Home Care, and Others) The Europe injection pen market is expected to grow from US$ 11,194.60 million in 2022 to US$ 16,749.04 million by 2028. It is estimated to ... Read More
-
North America Injection Pen Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)
... Therapy), and End User (Hospitals and Clinics, Home Care, and Others) The North America injection pen market is expected to grow from US$ 13,156.60 million in 2022 to US$ 20,075.51 million by 2028. It is ... Read More
-
Global Biologicals for Systemic Lupus Erythematosus Market Growth (Status and Outlook) 2023-2029
... for Systemic Lupus Erythematosus sales in 2022, providing a comprehensive analysis by region and market sector of projected Biologicals for Systemic Lupus Erythematosus sales for 2023 through 2029. With Biologicals for Systemic Lupus Erythematosus sales ... Read More
-
Global Glucocorticoid for Systemic Lupus Erythematosus Market Growth (Status and Outlook) 2023-2029
... for Systemic Lupus Erythematosus sales in 2022, providing a comprehensive analysis by region and market sector of projected Glucocorticoid for Systemic Lupus Erythematosus sales for 2023 through 2029. With Glucocorticoid for Systemic Lupus Erythematosus sales ... Read More
-
Global Immunosuppressant for Systemic Lupus Erythematosus Market Growth (Status and Outlook) 2023-2029
... for Systemic Lupus Erythematosus sales in 2022, providing a comprehensive analysis by region and market sector of projected Immunosuppressant for Systemic Lupus Erythematosus sales for 2023 through 2029. With Immunosuppressant for Systemic Lupus Erythematosus sales ... Read More
-
Asia-Pacific Injection Pen Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Disposable Injection Pens and Reusable Injection Pens), Therapy (Diabetes, Growth Hormone Therapy, Autoimmune Diseases, Fertility, Cancer, and Others Therapy), and End User (Hospitals and Clinics, Home Care, and Others)
... and End User (Hospitals and Clinics, Home Care, and Others) The Asia-Pacific injection pen market is expected to grow from US$ 11,116.23 million in 2022 to US$ 17,161.96 million by 2028. It is estimated to ... Read More
-
Systemic Lupus Erythematosus and Lupus Nephritis Epidemiology Analysis and Forecast, 2021-2031
... life-threatening illness (Tsokos, 2011). In SLE, the immune system attacks its own tissues, causing widespread inflammation and tissue damage in the affected organs (Centers for Disease Control and Prevention, 2022). SLE is also referred to ... Read More
-
Lupus Nephritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Lupus Nephritis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Biosimilars Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Indication (Cancer, Diabetes, Autoimmune Diseases, and Other Diseases), Drug Class (Granulocyte Colony-Stimulating Factors, Human Growth Hormone, Insulin, TNF Blockers & Monoclonal Antibodies, Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others)
... Erythropoietin-Stimulating Agents, and Others), Route of Administration (Intravenous, Subcutaneous, and Others), and End User (Hospitals, Speciality Clinics, Homecare, and Others) The biosimilars market was valued at US$ 18,435.89 million in 2021 and is expected to ... Read More
-
Eosinophilic Esophagitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Eosinophilic Esophagitis pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
-
Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Regi
... erythematosus (SLE) drugs market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.7% during 2023-2028.The increasing ... Read More
-
Global Systemic Lupus Erythematosus (SLE) Drugs Market Growth 2023-2029
... for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and ... Read More
-
Global Autoimmune Disorders Treatment Market Growth (Status and Outlook) 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Autoimmune Disorders Treatment sales for 2023 through 2029. With Autoimmune Disorders Treatment sales broken down by region, market sector and sub-sector, this report ... Read More
-
Global Animal Autoimmune Diseases Testing Market Growth (Status and Outlook) 2023-2029
... the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition. Sometimes, autoimmune cells will get activated due to molecular imitation between pathological antigens and self. Animal ... Read More
-
Global Autoimmune Disorders Treatment Market Research Report 2022 - Market Size, Current Insights and Development Trends
... competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to ... Read More
-
Rare Disease Clinical Trials Market Size, Share & Trends Analysis Report By Therapeutic Area (Autoimmune & Inflammation, Hematologic Disorders), By Phase (Phase I, Phase II), By Sponsor, By Region, And Segment Forecasts, 2023 - 2030
... Rare Disease Clinical Trials Market Growth & Trends The global rare disease clinical trials market size is expected to reach USD 24.25 billion by 2030, expanding at 9.7% CAGR from 2023 to 2030, according to ... Read More
-
Autoimmune and Inflammatory Immunomodulator Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... is expected to register solid growth in the sector in 2023 and beyond. The Autoimmune and Inflammatory Immunomodulator market report analyzes the Autoimmune and Inflammatory Immunomodulator market growth opportunities, trends, insights, and market size outlook ... Read More
-
Autoimmune Disease Diagnostics Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... to register solid growth in the sector in 2023 and beyond. The Autoimmune Disease Diagnostics market report analyzes the Autoimmune Disease Diagnostics market growth opportunities, trends, insights, and market size outlook across types, applications, and ... Read More
Research Assistance
